Monday 18th September 2023
|Text too small?|
TruScreen Group Limited (NZX/ASX:TRU) is pleased to report that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia.
Dr Sulaiman Al-Habib Medical Group (DSAMG) is the largest private hospital network in the Middle East. The adoption of TruScreen’s screening technology by DSAMG private hospitals will be important reference sites for further market access in neighbouring Middle Eastern nations.
This installation follows from the previously announced successful completion of the clinical evaluation by DSAMG network, followed by a successful tender by BettaLife Trading FZC (BettaLife) (Truescreen’s distributor in the Middle East).
The excellent clinical results of the evaluation were announced previously: see link
TruScreen’s CEO, Dr Beata Edling said:
“I am very pleased that the Dr Sulaiman Al-Habib Medical Group have approved and will use TruScreen technology to advance the screening for cervical cancer in their hospital network.
We congratulate BettaLife, our partner in Saudi Arabia, on reaching this important milestone which will support the expansion of the TruScreen operations in the Middle East.”
This announcement has been approved by the Board.
No comments yet
Me Today - Notice of Annual Shareholder Meeting
FSF - Director Scott St John to retire from Fonterra Board
Greenfern announces change in Chief Financial Officer
AIA Provision of Financial Assistance - Employee Share Plan
CBD - Recording and Presentation of Investor Call
AUCKLAND CAR PARK CONCESSION AGREEMENT - HIGH COURT JUDGMENT
CRP - Korella North Mining Lease Lodgement Approved
Genesis Energy launches new strategy
November 30th Morning Report
IFT270 - Interest Rate Reset